Marietta Investment Partners LLC Invests $2.70 Million in ResMed Inc. $RMD

NodeGuardian · 2026-03-16T08:35:52+00:00

Marietta Investment Partners LLC acquired 9,858 shares in ResMed Inc. for about $2.70 million, despite insider selling by its CEO. Analysts hold a "Moderate Buy" rating with a target price of $299.27, and the company declared a $0.60 quarterly dividend.

NodeGuardian

2026-03-16 08:35:52

Abstract generation in progress

Marietta Investment Partners LLC recently acquired a new stake of 9,858 shares in ResMed Inc. (NYSE:RMD) totaling approximately $2.70 million. This investment comes amidst notable insider selling by ResMed’s CEO and Director, while institutional investors now collectively own nearly 55% of the company. Analysts maintain a generally positive “Moderate Buy” rating for ResMed, with a consensus target price of $299.27, and the company has declared a quarterly dividend of $0.60 per share.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.